How Tresiba® works
Tresiba® is available in a vial or the FlexTouch® pen. Once injected, Tresiba® helps the sugar in your blood get into your cells. Sugar provides your cells with the energy needed to fuel your body.
actor portrayal
The unique molecular design of Tresiba® allows it to connect like a string of pearls.
Tresiba® releases slow and steady from the ends of its molecular chain for a full 24 hours of blood sugar management with powerful A1C reduction.
For adults, if you miss or delay your Tresiba® dose, simply take it as soon as you can, then return to your normal dosing schedule. Just be sure to leave at least 8 hours between doses.
What is Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL?
Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Do not take Tresiba® if you:
Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are:
Talk to your health care provider about low blood sugar and how to manage it.
Tresiba® may cause serious side effects that can be life-threatening, including:
Your insulin dose may need to change because of change in level of physical activity or exercise, increased stress, change in diet, weight gain or loss, or illness.
Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.
Please see Prescribing Information for Tresiba®.
Tresiba® is a prescription medication.
Find help with insulin costs at Novocare.com/letushelp.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
What is Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL?
Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Do not take Tresiba® if you:
Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are:
Talk to your health care provider about low blood sugar and how to manage it.
Tresiba® may cause serious side effects that can be life-threatening, including:
Your insulin dose may need to change because of change in level of physical activity or exercise, increased stress, change in diet, weight gain or loss, or illness.
Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.
Please see Prescribing Information for Tresiba®.
Tresiba® is a prescription medication.
Find help with insulin costs at Novocare.com/letushelp.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Fiasp®, FlexTouch®, Levemir®, NovoCare®, NovoFine®, NovoLog®, NovoLog® Mix 70/30, Tresiba®, and Xultophy® are registered trademarks of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
© 2024 Novo Nordisk All rights reserved. US24TSM00013 June 2024